Industry
Biotechnology
Topic
IPOs
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
IPOs in Biotechnology
... Allogene Therapeutics, Inc., a clinical-stage biotechnology company pioneering the development of allogeneic CAR T(AlloCAR ...
... Retinal disease company Kodiak Sciences Inc said on Wednesday that it has priced its initial public offering ...
... Kodiak Sciences Inc. ("Kodiak") today announced the pricing of its initial public offering of ...
... $ 12 million before the underwriting discount and offering expenses payable by Altimmune. In addition, Altimmune has granted the underwriters a 30-day overallotment option to ...
... Epizyme, Inc. (Nasdaq:EPZM), a clinical-stage company developing novel epigenetic therapies, today announced the pricing ...
... RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company developing the next generation of immuno-oncology ...
... SAN DIEGO - Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed ...
... SAN DIEGO, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed ...
... rich as him. A pot company is now as big as CBS Tilray, a Canadian maker of cannabis products, surged as much as 94 percent ...
... Labs, NEO Global Capital and 500 Startups. [ts_bullet_primary] Integrate.ai , a Toronto-based AI software company, raised $30 million in Series A funding. Portag3 Ventures led ...
Subscribe now for full coverage on IPOs in Biotechnology
Start My Free Trial